Plasmacytoid dendritic cells (pDCs) rapidly secrete type I interferon (interferon ?/?, IFN) in response to virus-derived nucleic acids, facilitating both innate and adaptive antiviral responses. Conversely, aberrant IFN production by pDCs is associated with autoimmune diseases, establishing pDCs as important emerging therapeutic targets. The overall goal of this project is to elucidate the molecular control of pDCs lineage, including its development, homeostasis and function in various immune responses. In the previous award cycles, we have identified E protein transcription factor TCF4 (E2-2) and several other factors as important regulators of pDC development. The proposed work will build upon these findings to address major unanswered questions in pDC biology.
In Aim 1, we will use high-dimensional single-cell analysis methods to characterize the stage and regulation of pDC lineage specification, as well as the functional heterogeneity of mature pDCs.
In Aim 2, we will use genetic approaches to dissect transcriptional control and regulation of the unique IFN-producing capacity of pDCs. Collectively, the proposed studies should yield a comprehensive molecular view of pDC development and function, paving the way for therapeutic approaches focused on this cell type.

Public Health Relevance

Plasmacytoid dendritic cells (pDCs) play an important role in immune responses to infection and in autoimmunity, and therefore represent attractive targets for novel immunoterapies. The proposed work aims to build a comprehensive molecular view of pDC development and function, paving the way for pDC- focused translational approaches in human diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI072571-14
Application #
9980767
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Vazquez-Maldonado, Nancy
Project Start
2007-12-15
Project End
2023-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
14
Fiscal Year
2020
Total Cost
Indirect Cost
Name
New York University
Department
Pathology
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Sawai, Catherine M; Serpas, Lee; Neto, Antonio Galvao et al. (2018) Plasmacytoid Dendritic Cells Are Largely Dispensable for the Pathogenesis of Experimental Inflammatory Bowel Disease. Front Immunol 9:2475
Upadhaya, Samik; Sawai, Catherine M; Papalexi, Efthymia et al. (2018) Kinetics of adult hematopoietic stem cell differentiation in vivo. J Exp Med 215:2815-2832
Soni, Chetna; Reizis, Boris (2018) DNA as a self-antigen: nature and regulation. Curr Opin Immunol 55:31-37
Lau, Colleen M; Tiniakou, Ioanna; Perez, Oriana A et al. (2018) Transcription factor Etv6 regulates functional differentiation of cross-presenting classical dendritic cells. J Exp Med 215:2265-2278
Kirkling, Margaret E; Cytlak, Urszula; Lau, Colleen M et al. (2018) Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells. Cell Rep 23:3658-3672.e6
Reizis, Boris; Colonna, Marco; Trinchieri, Giorgio et al. (2011) Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? Nat Rev Immunol 11:558-65